ES2184885T3 - Derivados aza-antraciclinona. - Google Patents

Derivados aza-antraciclinona.

Info

Publication number
ES2184885T3
ES2184885T3 ES96927580T ES96927580T ES2184885T3 ES 2184885 T3 ES2184885 T3 ES 2184885T3 ES 96927580 T ES96927580 T ES 96927580T ES 96927580 T ES96927580 T ES 96927580T ES 2184885 T3 ES2184885 T3 ES 2184885T3
Authority
ES
Spain
Prior art keywords
sub
anthraciclinone
aza
derivatives
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96927580T
Other languages
English (en)
Inventor
Michele Caruso
Daniela Fiardi
Tiziano Bandiera
Jacqueline Lansen
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of ES2184885T3 publication Critical patent/ES2184885T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPUESTOS DE FORMULA (1) EN DONDE X SUB,1} Y X SUB,2} SON C = O, C = NH O CH SUB,2}, X SUB,3} ES CH SUB,2}, CO, CHOH, DE FORMULA (III), DE FORMULA (IV) EN DONDE N=2 O 3, Y C = N(R SUB,9}) EN DONDE R SUB,9} ES HIDROXI O AMINO-ARILO, Y CADA UNO DE LOS R SUB,1}, R SUB,2}, R SUB,3}, R SUB,4}, R SUB,5}, R SUB,6}, R SUB,7} Y R SUB,8} SON HIDROGENO, HALOGENO O UN RESIDUO ORGANICO, UTILES EN EL TRATAMIENTO DE LA AMILOIDOSIS. TAMBIEN SE DESCRIBE UN PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES96927580T 1995-08-09 1996-07-23 Derivados aza-antraciclinona. Expired - Lifetime ES2184885T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516349.9A GB9516349D0 (en) 1995-08-09 1995-08-09 Aza-anthracyclinone derivatives

Publications (1)

Publication Number Publication Date
ES2184885T3 true ES2184885T3 (es) 2003-04-16

Family

ID=10779013

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96927580T Expired - Lifetime ES2184885T3 (es) 1995-08-09 1996-07-23 Derivados aza-antraciclinona.

Country Status (22)

Country Link
US (1) US5985887A (es)
EP (1) EP0843675B1 (es)
JP (1) JPH11510500A (es)
KR (1) KR100449580B1 (es)
CN (1) CN1063178C (es)
AR (1) AR010200A1 (es)
AT (1) ATE225347T1 (es)
CA (1) CA2227984C (es)
DE (1) DE69624122T2 (es)
DK (1) DK0843675T3 (es)
ES (1) ES2184885T3 (es)
GB (1) GB9516349D0 (es)
IL (1) IL123000A (es)
NO (1) NO317825B1 (es)
NZ (1) NZ315609A (es)
PL (1) PL185305B1 (es)
PT (1) PT843675E (es)
RU (1) RU2159245C2 (es)
TW (1) TW327170B (es)
UA (1) UA48983C2 (es)
WO (1) WO1997006165A1 (es)
ZA (1) ZA966665B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701628D0 (en) * 1997-01-27 1997-03-19 Pharmacia & Upjohn Spa Imino-aza-anthracyclinone derivatives
GB9805080D0 (en) 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Amino anthracyclinone derivatives
GB9805082D0 (en) * 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Heterocyclyl anthracyclinone derivatives
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US8846882B2 (en) 2011-04-29 2014-09-30 Synbias Pharma Ag Method of producing 4-demethoxydaunorubicin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110289A (en) * 1993-08-06 1998-01-04 Policlinico San Matteo Istitut Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis
GB9416007D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
GB9418260D0 (en) * 1994-09-09 1994-10-26 Erba Carlo Spa Anthracycline derivatives

Also Published As

Publication number Publication date
CA2227984C (en) 2006-07-11
EP0843675B1 (en) 2002-10-02
ATE225347T1 (de) 2002-10-15
IL123000A (en) 2000-10-31
ZA966665B (en) 1997-05-12
CN1194646A (zh) 1998-09-30
NO317825B1 (no) 2004-12-13
AR010200A1 (es) 2000-06-07
EP0843675A1 (en) 1998-05-27
IL123000A0 (en) 1998-08-16
CN1063178C (zh) 2001-03-14
KR19990036275A (ko) 1999-05-25
UA48983C2 (uk) 2002-09-16
AU712411B2 (en) 1999-11-04
JPH11510500A (ja) 1999-09-14
GB9516349D0 (en) 1995-10-11
DE69624122T2 (de) 2003-03-20
NO980518L (no) 1998-03-31
DK0843675T3 (da) 2003-02-10
US5985887A (en) 1999-11-16
DE69624122D1 (de) 2002-11-07
PL324892A1 (en) 1998-06-22
WO1997006165A1 (en) 1997-02-20
CA2227984A1 (en) 1997-02-20
KR100449580B1 (ko) 2004-12-03
TW327170B (en) 1998-02-21
PT843675E (pt) 2002-12-31
NZ315609A (en) 1999-11-29
MX9801045A (es) 1998-10-31
PL185305B1 (pl) 2003-04-30
RU2159245C2 (ru) 2000-11-20
NO980518D0 (no) 1998-02-06
AU6735996A (en) 1997-03-05

Similar Documents

Publication Publication Date Title
GEP20074251B (en) N-oxycarbonyl substituted 5&#39;- deoxy-5-fluorocytidines
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
MX9805253A (es) Antagonistas del receptor de vitronectina.
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
HU9301362D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
ES2158452T3 (es) Uso de agonistas y antagonistas de estrogenos en la fabricacion de un medicamento para el tratamiento de la ateroesclerosis, independientemente de la disminucion de lipidos.
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
ATE176911T1 (de) 2&#39;-desoxy-isoguanosine, isostere analoge und isoguanosinderivate sowie deren anwendung
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
ZA914133B (en) Preparation of substituted piperidines
ES2184885T3 (es) Derivados aza-antraciclinona.
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
ES2170855T3 (es) Derivados de 1,4-benzodioxina.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
IL95327A0 (en) Method and composition for the treatment of cardiac and of vascular hypertrophy and hyperplasia
NZ334553A (en) N-(2-Benzothiazolyl) piperidine-1 ethanamine derivatives and pharmaceutical use
ATE247955T1 (de) Selenophen-antitumormittel
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
ES2195313T3 (es) Derivados de imino-aza-antraciclinona para el tratamiento de la amiloidosis.
ES2040750T3 (es) Un procedimiento para la preparacion de un derivado de isoquinolinol.